Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
robin, there's no news yet give it time. They have to become familiar with the in depth details of the entire company. Before they won the proxy fight they weren't privy to review the financials similar to an audit that takes months. Not saying there won't be any PR but everything takes time.
Bolio, well that sucks. I think there's more to the formula.
CBB, KM is needed at the moment for his knowledge of the intricate operations of the various stages of the applications in the works of all the regions of the EU. AD will keep KM on till he's done with him. We need a new CEO which will take a while, he'll probably move up one of the new board members to CEO and could include a performance based package instead of millions of free shares. I think we have to wait for the proxy to be filed.
sleven, thanks I missed the call anything interesting?
newman, not aware of a conference coming up this Monday, can you provide a link or something? Is it on the amarin website?
lemmiwinks, that would be a kick in the b-lls to KM. K still needs to feel he's of value to the company in order to move the EU approval forward.
Meowzo, if sarissa doesn't have a broker dealer license he must use his prime brokers who will execute their orders. I'm sure they have several prime brokers. Self clearing is very dangerous and requires very strict SEC standards.
not sure if this article has been posted, apologies if so
https://www.fiercepharma.com/pharma/sarissas-overhaul-amarins-board-complete-resignation-7-holdover-members?_gl=1*1oehcpo*_ga*MTI0NjE3OTg2My4xNjc4MjI5MzUy*_ga_KG49J84SR4*MTY3ODIyOTM1Mi4xLjEuMTY3ODIyOTQxMy4wLjAuMA..
kiwi, as someone here said isn't it better to have your resume say you resigned rather than getting sacked from the bod. I'm hoping to hear something from Sarissa next which may be the newly nominated COB.
MMS, it's interesting to see the 7 out of 8 bod left immediately. I wonder what was said for all to book the joint. LOL Kind of like pac-man chomping on the dots.
mr stockboy, So my take is the new BOD is digging into the company starting with the financials and where they can cut costs. Once they figure out the cost cutting aspect they'll start by booting out the unneeded personnel. I think we're looking at 2024 before there will be a serious "for sale" sign or partnership in the works.
Wouldn't it be nice to start an advertising campaign and take Vascepa out of the closet before the patents expire. Time is not our friend.
jroon, I think the next proxy meeting for 2023 which will probably be sometime in June or July, and at that time they may change the option plan plus all the compensation packages based on performance which is what many companies are doing. There's more transparency with comp packages being disclosed by CEO's.
https://www.sec.gov/Archives/edgar/data/897448/000119312522158650/d651622ddef14a.htm#toc651622_13
https://www.sec.gov/Archives/edgar/data/897448/000119312522176598/d727055ddefa14a.htm
interesting wording in this PR. Very telling that they were forced out.
BRIEF-Amarin Announces Board Departures
REUTERS 6:45 PM ET 3/6/2023
Symbol Last Price Change
AMRN 1.86up -0.09 (-4.6154%)
QUOTES AS OF 04:00:01 PM ET 03/06/2023
March 6 (Reuters) - Amarin Corporation PLC(AMRN):
* AMARIN ANNOUNCES BOARD DEPARTURES
* AMARIN CORPORATION PLC(AMRN) - TO AVOID FURTHER PROXY CONTESTS, ALL 7 INDEPENDENT NON-SARISSA BOARD MEMBERS WILL RESIGN EFFECTIVE IMMEDIATELY Source text for Eikon: Further company coverage:
Did anyone notice the PR today did not contain the contact information for IR, Lisa, and the other guy, don't recall his name. I'm assuming there will be a massive firing of most people such as Lisa.
capt, correct but the shares which have been acquired or awarded according to the last update of the proxy can't be taken back and placed back into the authorized shares. Unless there's something stated in the last filed proxy from 2022 I'm not aware of it.
Now that I think about it, the ridiculous amount of shs that would be awarded to KM if there's a change in control of the company could be a good reason to sack KM after they pick his brains. It would be less dilutive by over 5mill shares if Denner wants to negotiate a sale it would be a factor in pricing for sure. So the fewer shares issued to management etc the better for the company when it comes to a sale.
newman2021, yeah cause Nissen knows now that the new guard is at the door of Amarin he'll take a backseat and stop the criticisms of vascepa. It's a different time for the company going forward. For all that has followed what has transpired over the past year or so knows that Sarissa plays for keeps with a don't shit on me kind of attitude that came across as very strong after the news today.
sts66, proxy votes were in an 8K filed with the SEC on 3/2/23
sts66, proxy votes were in an 8K filed with the SEC on 3/2/23
invest83, As a matter of fact, the Sarissa crew has the experience needed to replace some of the existing management. We'll have to wait till they PR the changes and file their 8K's.
Denner knows the value of V and has a plan in mind to change the direction of the company. There's so much waste, he needs to strip middle management down to bare necessities and get rid of Bridgewater. Also, upgrade that awful website!! amateur hour.
sts66, PWO was gone immediately after the votes came in on Feb 28.
Interesting that KM is still in the mix. He may stay on since he's the hands on person in the day to day operations. Eventually, after he serves his purpose he'll be sacked as well. Otherwise too much too soon.
yahoo!!!!
Amarin Announces Board Departures
GLOBENEWSWIRE 4:05 PM ET 3/6/2023
Symbol Last Price Change
AMRN 1.86up -0.09 (-4.6154%)
QUOTES AS OF 04:00:01 PM ET 03/06/2023
DUBLIN, Ireland and BRIDGEWATER. N.J., March 06, 2023 (GLOBE NEWSWIRE) -- Amarin Corporation plc(AMRN) (“Amarin” or the “Company”) today announced that, in the interest of the Company to avoid further proxy contests, all seven independent non-Sarissa board members: Adam Berger, Erin Enright, Geraldine Murphy, Kristine Peterson, Dr. Murray Stewart, Jan van Heek and Alfonso “Chito” Zulueta will resign from the Board of Directors, effective immediately.
The departing members of the Amarin Board issued the following statement:
Following the 2023 Special Meeting of Shareholders, we have made the decision to resign from the Amarin Board. Amarin(AMRN) shareholders have strongly backed Sarissa and its slate of directors, and we are stepping down to allow Sarissa, as it has requested, to gain immediate control of the Company. We continue to believe in Amarin’s value potential, and are confident we leave the Company with a strong leadership and management team. We wish the new Sarissa directors good luck as they attempt to realize additional shareholder value.
About Amarin(AMRN)
Amarin (AMRN) is an innovative pharmaceutical company leading a new paradigm in cardiovascular disease management. From our foundation in
622fast, thanks gotta do more DD they have an impressive BOD.
Odysseas Kostas is on the BOD of ARMP Interesting little company.
https://www.armatapharma.com/about-us/board-of-directors/
funnygi2, LOL Amarin was playing amateur hour up against a pro the likes of Sarissa. I emailed IR a warning and encouraged them to play nice with Denner or they would lose the proxy contest. They decided to spend our money fighting a losing fight. We'll need a miracle to retrieve all the millions they lost because they were clueless. Dopey people.
capt, out of the 3 top voted for the board, using a process of elimination Kostas is Denner's right hand person and is on a few other boards. DiPaolo is Denner's in house counsel and is on the board of a couple of Denner's other companies. Diane is new to the Sarissa scene not on any of Denner's other company boards and her experience qualifies her for the COB of Amarin. But also here's another thought Dr. Sterling has skin in the game since he purchased 210,000 shs. So he may be another consideration.
more PR from amarin, I guess they'll PR this tomorrow as well.
Amarin Announced New REDUCE-IT Data Showing Benefit Of VASCEPA/VAZKEPA In High-Risk Patients With A Recent Acute Coronary Syndrome Event
BENZINGA 11:03 AM ET 3/5/2023
Symbol Last Price Change
AMRN 1.95up 0 (0%)
QUOTES AS OF 04:00:00 PM ET 03/03/2023
Amarin Corporation plc (NASDAQ:AMRN) today announced a new analysis from the VASCEPA/VAZKEPA (icosapent ethyl) cardiovascular outcomes REDUCE-IT study showing the effectiveness of VASCEPA®/VAZKEPA® in patients with recent acute coronary syndrome (<12 months before randomization). This post-hoc analysis showed that icosapent ethyl (IPE) substantially and significantly reduced the risk of first and total ischemic events by 37% and 36% respectively in patients with recent acute coronary syndrome (ACS) without increasing bleeding, supporting early initiation of IPE after ACS. The data were presented at the American College of Cardiology's 72nd Annual Scientific Session together with the World Heart Federation'sWorld Congress of Cardiology in New Orleans, LA.
has anyone questioned why this excerpt below
amarin annnoucement.
BRIEF-Amarin Announces New Data Showing Benefit Of Vascepa In High-Risk Patients With A Recent Acute Coronary Syndrome Event
REUTERS 10:28 AM ET 3/5/2023
Symbol Last Price Change
AMRN 1.95up 0 (0%)
QUOTES AS OF 04:00:00 PM ET 03/03/2023
March 5 (Reuters) - Amarin Corporation PLC(AMRN):
* AMARIN ANNOUNCES NEW REDUCE-IT® DATA AT ACC.23/WCC SHOWING BENEFIT OF VASCEPA®/VAZKEPA® (ICOSAPENT ETHYL) IN HIGH-RISK PATIENTS WITH A RECENT ACUTE CORONARY SYNDROME EVENT Source text for Eikon: Further company coverage:
capt, if I'm not mistaken she was the top pick for COB.
does anyone care?
We’re looking forward to the latest REDUCE-IT data being presented today at #ACC23/#WCCardio. Catch these new data updates at the meeting.
— Amarin (@Amarincorp) March 5, 2023
Newman, not yet revealed
Duke, thanks I didn't see the drop down menu. I see they've added the newly proxitized board members. Yeah!
North, Sorry for the delayed response just catching up. Actually, there are so many factors that would determine the true value of vascepa/amarin it depends on the time and status of the company. I'll leave it up to the pro's who package companies. We have many months of restructuring ahead of us I'm prepared for many surprises that'll pop up during Sarissa's deep drive into the financials e g what's real and what's false rhetoric that's been talked about for a few years. Thank God we won the proxy contest. Now I know vascepa has a future.
DTG, please post the link with the BOD names. I can't find it, thanks
DTG, thanks but that's the leadership page. Not BOD page.
Anyone out there....can you find the board of directors on the disgraceful- awful website for Amarin?
meowzo, maybe if seized before that happens, remote control? It's all air.
jasbg, I agree that it's a coin toss but on the outside looking in especially for large investors and potential partners if they start the negotiations with the COB they know they're starting at the top and won't have to play telephone with other board members.